BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549:BRAF Fusion Variants

di Lin, Alex, Rodriguez, Fausto J., Karajannis, Matthias A., Williams, Susan C., Legault, Genevieve, Zagzag, David, Burger, Peter C., Allen, Jeffrey C., Eberhart, Charles G., Bar, Eli E.
Pubblicato in J Neuropathol Exp Neurol (2012)

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas

di Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Ballas, Marc S., Brown, Krysten, Nusbaum, Annette O., Hochman, Tsivia, Goldberg, Judith D., Koch, Kevin M., Golfinos, John G., Roland, J. Thomas, Allen, Jeffrey C.
Pubblicazione 2012

Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas

di Karajannis, Matthias A., Legault, Geneviève, Hagiwara, Mari, Giancotti, Filippo G., Filatov, Alexander, Derman, Anna, Hochman, Tsivia, Goldberg, Judith D., Vega, Emilio, Wisoff, Jeffrey H., Golfinos, John G., Merkelson, Amanda, Roland, J. Thomas, Allen, Jeffrey C.
Pubblicazione 2014

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

di Perreault, Sébastien, Larouche, Valérie, Tabori, Uri, Hawkin, Cynthia, Lippé, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Métras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Éric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Pubblicato in BMC Cancer (2019)

CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01

di Perreault, Sébastien, larouche, Valérie, Tabori, Uri, Hawkins, Cynthia, Lippe, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Metras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Eric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Pubblicato in Neuro Oncol (2020)

LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01

di Perreault, Sébastien, Larouche, Valérie, Tabori, Uri, Hawkins, Cynthia, Lippé, Sarah, Ellezam, Benjamin, Décarie, Jean-Claude, Théoret, Yves, Métras, Marie-Élaine, Sultan, Serge, Cantin, Édith, Routhier, Marie-Ève, Caru, Maxime, Legault, Geneviève, Bouffet, Eric, Lafay-Cousin, Lucie, Hukin, Juliette, Erker, Craig, Jabado, Nada
Pubblicato in Neuro Oncol (2020)

Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas

di Karajannis, Matthias A., Legault, Geneviève, Fisher, Michael J., Milla, Sarah S., Cohen, Kenneth J., Wisoff, Jeffrey H., Harter, David H., Goldberg, Judith D., Hochman, Tsivia, Merkelson, Amanda, Bloom, Michael C., Sievert, Angela J., Resnick, Adam C., Dhall, Girish, Jones, David T. W., Korshunov, Andrey, Pfister, Stefan M., Eberhart, Charles G., Zagzag, David, Allen, Jeffrey C.
Pubblicazione 2014

Canadian Pediatric Neuro-Oncology Standards of Practice

di Bennett, Julie, Erker, Craig, Lafay-Cousin, Lucie, Ramaswamy, Vijay, Hukin, Juliette, Vanan, Magimairajan I., Cheng, Sylvia, Coltin, Hallie, Fonseca, Adriana, Johnston, Donna, Lo, Andrea, Zelcer, Shayna, Alvi, Saima, Bowes, Lynette, Brossard, Josée, Charlebois, Janie, Eisenstat, David, Felton, Kathleen, Fleming, Adam, Jabado, Nada, Larouche, Valérie, Legault, Geneviève, Mpofu, Chris, Perreault, Sébastien, Silva, Mariana, Sinha, Roona, Strother, Doug, Tsang, Derek S., Wilson, Beverly, Crooks, Bruce, Bartels, Ute
Pubblicato in Front Oncol (2020)